Search Results - "Krupitsky, E.M"

The mRNA expression status of the 5-HT2A receptor in blood peripheral mononuclear cells of schizophrenia patients: biomarker of the efficacy of olanzapine treatment by Nasyrova, R.F, Taraskina, A.E, Sosin, D.N, Ershov, E.E, Zabotina, A.M, Ivashchenko, D.V, Sosina, K.A, Grunina, M.N, Pchelina, M.M, Krupitsky, E.M

Get full text

Psychometric Properties and Factor Structure of the Russian Version of the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) by Klimanova, S.G., Trusova, A.V., Kiselev, A.S., Berntsev, V.A., Gromyko, D.I., Ilyuk, R.D., Krupitsky, E.M.

“…The article presents the results of adaptation of the Russian version of the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES, ver. 8A, 8D)…”
Get full text

P.3.04 Neurocognitive functioning in patients with different type of abuse by Bushara, N, Fishbein, D.H, Flannery, B.A, Langevin, D.J, Bobashev, G, Zvartau, E.E, Verbitskaya, E.V, Tsoy, M.V, Krupitsky, E.M, Egorova, V.U

Get full text

P.0315 Association between hazardous alcohol use and initiation of naltrexone treatment for opioid use disorder among hiv-positive persons in russia by Vetrova, M., Blokhina, E.A., Cheng, D.M., Truong, V., Quinn, E.K., Gnatienko, N., Bushara, N.M., Palatkin, V.Y., Vasilyeva, J.V., Yaroslavtseva, T.S., Krupitsky, E.M., Lioznov, D.A., Samet, J.H.

Get full text

Risk for antipsychotic-induced extrapyramidal symptoms: a focus on monoamine receptors on peripheral blood lymphocytes by Zabotina, A., Grunina, M.N., Nasyrova, R.F., Pchelina, M.M., Ershov, E.E., Krupitsky, E.M., Taraskina, A.E.

Get full text

P.1.a.039 - Histamine H1 receptor level in peripheral blood lymphocytes of schizophrenic patients as possible diagnostic marker of olanzapine treatment efficacy by Zabotina, A.M., Taraskina, A.E., Nasyrova, R.F., Sosin, D.N., Sosina, K.A., Ershov, E.E., Grunina, M.N., Krupitsky, E.M.

Get full text

Histamine H1 receptor level in peripheral blood lymphocytes of schizophrenic patients as possible diagnostic marker of olanzapine treatment efficacy by Zabotina, A.M., Taraskina, A.E., Nasyrova, R.F., Sosin, D.N., Sosina, K.A., Ershov, E.E., Grunina, M.N., Krupitsky, E.M.

Get full text

Evolution of illicit opioids used among people with HIV in St. Petersburg, Russia, in the period 2004–2015 by Blokhina, E., Krupitsky, E.M., Cheng, D.M., Walley, A.Y., Toussova, O., Yaroslavtseva, T., Gnatienko, N., Bridden, C., Forman, L.S., Bendiks, S., Samet, J.H.

Get full text

P.3.b.030 - The mRNA expression status of the 5-HT2A receptor in blood peripheral mononuclear cells of schizophrenia patients: biomarker of the efficacy of olanzapine treatment by Nasyrova, R.F., Taraskina, A.E., Sosin, D.N., Ershov, E.E., Zabotina, A.M., Ivashchenko, D.V., Sosina, K.A., Grunina, M.N., Pchelina, M.M., Krupitsky, E.M.

Get full text

Psychometric Properties and Factor Structure of the Russian Version of the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) by Klimanova, S.G., Trusova, A.V., Kiselev, A.S., Berntsev, V.A., Gromyko, D.I., Ilyuk, R.D., Krupitsky, E.M.

Get full text

The Key Proteins of Dopaminergic Neurotransmission of Human Peripheral Blood Lymphocytes: Changed mRNA Level in Alcohol Dependence Syndrome by Taraskina, A. E., Grunina, M. N., Zabotina, A. M. R., Nasyrova, F., Ivanov, M. V., Krupitsky, E. M., Schwartzman, A. L.

“…The expression of dopamine receptor ( DRD ), Nurr1 transcription factor ( NR4A2 ), and α-sinucleine ( SNCA ) genes in peripheral blood lymphocytes is…”
Get full text

P.6.038 Statistical analysis of double blind placebo controlled clinical trial of heroin addiction treatment by naltrexone and fluoxetine combination by Verbitskaya, E.V., Krupitsky, E.M., Zvartau, E.E.

Get full text

Co-morbidity of infectious and addictive diseases in St. Petersburg and the Leningrad Region, Russia by Krupitsky, E M, Zvartau, E E, Lioznov, D A, Tsoy, M V, Egorova, V Y, Belyaeva, T V, Antonova, T V, Brazhenko, N A, Zagdyn, Z M, Verbitskaya, E V, Zorina, Y, Karandashova, G F, Slavina, T Y, Grinenko, A Y, Samet, J H, Woody, G E

“…The Russian health care system is organized around specific diseases, with relatively little focus on integration across specialties to address co-morbidities…”
Get more information

P.3.10 Ethanol-like effects of N-methyl- d-aspartatereceptors antagonist memantine, and its ability to prevent cue induced alcohol craving by Tsoy, M., Krupitsky, E.M., Neznanova, O.N., Burakov, A.M., Didenko, T.Y., Masalov, D.V., Romanova, T.N., Bespalov, A.Y., Zvartau, E.E., Krystal, J.

Get full text

P.3.23 Naltrexone for treatment of heroindependence in Russia by Egorova, V., Krupitsky, E.M., Zvartau, E.E., Masalov, D.V., Tsoi, M.V., Burakov, A.M., Didenko, T.Y, Romanova, T.N., Ivanova, E.B., Bespalov, A.Y., Verbitskaya, E., Neznanov, N.G., Grinenko, A.Y., Woody, G.

Get full text

P.5.016 Nimodipine attenuate memory disturbances caused by subanaesthetic dose of ketamine in sober alcoholic patients by Krupitsky, E.M., Ivanov, V.B., Priputina, L.S., Grinenko, A.Y.

Get full text

Baclofen administration for the treatment of affective disorders in alcoholic patients by Krupitsky, E M, Burakov, A M, Ivanov, V B, Krandashova, G F, Lapin, I P, Grinenko AJa, Borodkin YuS

“…Ninety alcoholic patients with the secondary affective disorders (anxiety, depression) were divided into four groups. Patients in the first group received…”
Get more information

Prevention of suicide by naltrexone in a recently detoxified heroin addict by Krupitsky, E M, Masalov, D V, Didenko, T Y, Burakov, A M, Romanova, T N, Zvartau, E E, Woody, G

“…This case describes a heroin addict who was participating in a placebo-controlled randomized trial of naltrexone as an aid to relapse prevention. The patient…”
Get more information

The administration of transcranial electric treatment for affective disturbances therapy in alcoholic patients by Krupitsky, E M, Burakov, A M, Karandashova, G F, Katsnelson JaS, Lebedev, V P, Grinenko AJa, Borodkin JuS

“…In a double blind placebo-controlled investigation it was shown that transcranial electric treatment (TET), comprising the combination of a constant current…”
Get more information